(Q34272029)

1 August 2017

1 reference

title

Prevention of cervical cancer with vaccines (English)

1 reference

1 August 2017

main subject

cervix uterine cancer

1 reference

Im SS

1

1 reference

1 August 2017

Monk BJ

series ordinal

2

1 reference

1 August 2017

Villarreal LP

series ordinal

3

1 reference

1 August 2017

publication date

1 July 2001

1 reference

1 August 2017

published in

Current Oncology Reports

1 reference

1 August 2017

volume

3

1 reference

1 August 2017

issue

4

1 reference

1 August 2017

page(s)

322-328

1 reference

Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus.

1 August 2017

cites work

1 reference

12 December 2020

Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera

1 reference

12 December 2020

A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive.

1 reference

12 December 2020

Papillomavirus lesions in immunodepression and immunosuppression

1 reference

12 December 2020

Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma.

1 reference

12 December 2020

Human papillomaviruses and cervical neoplasia: a model for carcinogenesis

1 reference

12 December 2020

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model

1 reference

12 December 2020

Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization

1 reference

12 December 2020

Immunization with human papillomavirus type 16 (HPV16) oncoprotein-loaded dendritic cells as well as protein in adjuvant induces MHC class I-restricted protection to HPV16-induced tumor cells

1 reference

12 December 2020

Developing HPV virus-like particle vaccines to prevent cervical cancer: a progress report

1 reference

12 December 2020

Induction of HPV16 capsid protein-specific human T cell responses by virus-like particles

1 reference

12 December 2020

Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice

1 reference

12 December 2020

Estimates of the worldwide incidence of 25 major cancers in 1990.

1 reference

12 December 2020

Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumors

1 reference

12 December 2020

Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions

1 reference

12 December 2020

The open reading frame L2 of cottontail rabbit papillomavirus contains antibody-inducing neutralizing epitopes

1 reference

12 December 2020

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic

1 reference

12 December 2020

Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.

1 reference

12 December 2020

Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine

1 reference

12 December 2020

Natural HPV immunity and vaccination strategies

1 reference

12 December 2020

Immunization against bovine papillomavirus infection

1 reference

12 December 2020

Yohei Ito Memorial Lecture: Papillomaviruses in human cancers

1 reference

12 December 2020

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

12 December 2020

Chimeric virus-like particles of the human papillomavirus type 16 (HPV 16) as a prophylactic and therapeutic vaccine

1 reference

12 December 2020

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

1 reference

12 December 2020

DNA inoculations with HIV-1 recombinant genomes that express cytokine genes enhance HIV-1 specific immune responses

1 reference

12 December 2020

Evaluation of the risk of cervical intraepithelial neoplasia and human papilloma virus infection in renal transplant patients receiving immunosuppressive therapy.

1 reference

12 December 2020

Enhancement of DNA vaccine potency by linkage of antigen gene to a gene encoding the extracellular domain of Fms-like tyrosine kinase 3-ligand

1 reference

12 December 2020

Adjuvant-free hsp70 fusion protein system elicits humoral and cellular immune responses to HIV-1 p24

1 reference

12 December 2020

Antigen-specific cancer immunotherapy using a GM-CSF secreting allogeneic tumor cell-based vaccine

1 reference

12 December 2020

Nasal immunization of mice with human papillomavirus type 16 (HPV-16) virus-like particles or with the HPV-16 L1 gene elicits specific cytotoxic T lymphocytes in vaginal draining lymph nodes

1 reference

12 December 2020

Optimal induction of hepatitis C virus envelope-specific immunity by bicistronic plasmid DNA inoculation with the granulocyte-macrophage colony-stimulating factor gene.

1 reference

12 December 2020

Estimates of the worldwide mortality from 25 cancers in 1990.

1 reference

12 December 2020

Cervical dysplasia in HIV-seropositive women: role of human papillomavirus infection and immune status

1 reference

12 December 2020

Human papillomaviruses and genital cancer

1 reference

12 December 2020

Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I-II trial

1 reference

12 December 2020

Immunotherapy of a human papillomavirus (HPV) type 16 E7-expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette-Guérin (BCG) hsp65 and HPV16 E7.

1 reference

12 December 2020

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

1 reference

12 December 2020

Mucosal vaccination with a recombinant Salmonella typhimurium expressing human papillomavirus type 16 (HPV16) L1 virus-like particles (VLPs) or HPV16 VLPs purified from insect cells inhibits the growth of HPV16-expressing tumor cells in mice

1 reference

12 December 2020

Human papillomavirus type 16 E7 DNA vaccine: mutation in the open reading frame of E7 enhances specific cytotoxic T-lymphocyte induction and antitumor activity

1 reference

12 December 2020

A survey of seroprevalence of human papillomavirus types 16, 18 and 33 among children

1 reference

12 December 2020

Intramuscular administration of E7-transfected dendritic cells generates the most potent E7-specific anti-tumor immunity

1 reference

12 December 2020

Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer

1 reference

12 December 2020

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

1 reference

12 December 2020

Human papillomavirus vaccines for cervical cancer

1 reference

12 December 2020

Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene

1 reference

12 December 2020

Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas

1 reference

12 December 2020

Cell-mediated immunological responses in cervical and vaginal cancer patients immunized with a lipidated epitope of human papillomavirus type 16 E7.

1 reference

12 December 2020

10.1007/S11912-001-0084-6

Identifiers

DOI

1 reference

Dimensions Publication ID

1 August 2017

1018849570

0 references

1 reference